Physician
City Health, a Medical Corporation
City Health, a Medical Corporation was paid $3.75M by Medicaid between Jan 2018 and Nov 2024, across 26 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 37% of everything it billed.
33Billing provider infoCITY HEALTH, A MEDICAL CORPORATION
SAN LEANDRO, CA 94577
SAN LEANDRO, CA 94577
33aNPI1477940187assigned 04/20/2015
33bProvider typeDermatology Physician
28Total paid$3.75M
24GClaims109,338
24DCodes billed26
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Dermatology Physician providers in California
Rank by total paid#12 of 187
Median peer was paid$26K
This provider vs. median143×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,203 | $116K | |
| 2019 | 1,941 | $121K | |
| 2020 | 5,825 | $228K | |
| 2021 | 52,962 | $1.49M | |
| 2022 | 41,115 | $1.45M | |
| 2023 | 3,935 | $183K | |
| 2024incomplete | 1,357 | $157K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 37% | 29,731 | 29,384 | $1.37M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 20% | 13,634 | 11,265 | $749K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 19,192 | 17,546 | $537K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 3,631 | 3,245 | $360K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.6% | 2,224 | 2,203 | $286K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.9% | 4,149 | 4,027 | $147K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 3,377 | 3,103 | $85K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1.8% | 6,029 | 4,585 | $66K |
| 99000 | 1.5% | 22,508 | 21,215 | $57K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 2,998 | 2,047 | $56K |
| 87631 | <1% | 99 | 95 | $9K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 32 | 31 | $5K |
14 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 155 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 77 | $2K |
| 94060 | <1% | 51 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 145 | $2K |
| 81025 | <1% | 370 | $932.18 | |
| 81003 | <1% | 340 | $810.42 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 41 | $786.40 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 15 | $600.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 31 | $577.83 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 32 | $556.76 |
| 81002 | <1% | 273 | $460.25 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 24 | $362.91 |
| 81005 | <1% | 165 | $242.76 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPARKIN, SEAN (CEO)